Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Health Industry
1,901 - 1,920 of 3,938 Results
-
-
Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers
A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.
-
Delaneyâs Debate Claim That âMedicare For Allâ Will Shutter Hospitals Goes Overboard
At the first Democratic presidential primary debate, former U.S. lawmaker John Delaney outlined his opposition to âMedicare for Allâ by claiming it would prove fatal for hospitals. Itâs really not that simple.
-
KHNâs âWhat The Health?â: Dems Debate Health Care
Democratic presidential candidates disagreed on how to fix health care in their first debate Wednesday, although they all called for boosting insurance coverage and lowering prices. Meanwhile, the Trump administration is keeping health care in the news, too, with a new plan to make medical prices more available to the public. Stephanie Armour of The Wall Street Journal, Rebecca Adams of CQ Roll Call and Anna Edney of Bloomberg News join KHNâs Julie Rovner to discuss this, plus the latest in news about bipartisan progress on catch-all legislation to address âsurpriseâ medical bills. Plus, Rovner interviews NPRâs Jon Hamilton about the latest KHN-NPR âBill of the Monthâ installment.
-
âMedicare For Allâ Emerges As Early Divide In First Democratic Debate
On the first of the Democratâs two-night debate, only New York City Mayor Bill de Blasio and Massachusetts Sen. Elizabeth Warren offered full support for a single-payer system that would banish private health insurance.
-
Senate Panel Makes Surprisingly Fast Work Of âSurprise Medical Billsâ Package
The measure also includes a range of provisions designed to address health care costs.
By Rachel Bluth -
Middlemen Who Save $$ On Medicines â But Maybe Not For You
Guess whoâs back grabbing headlines? Pharmacy benefit managers â those companies that serve as middlemen in the prescription drug pipeline.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Surgeonsâ Opioid-Prescribing Habits Are Hard To Kick
A new data analysis by KHN and Johns Hopkins researchers shows that even as the CDC issued warnings, surgeons handed out many times the number of opioid pills needed for post-op pain.
By Julie Appleby and Elizabeth Lucas -
Opioid Operators: How Surgeons Ply Patients With Painkillers
Even as awareness of the opioid crisis grew, prescribing habits of surgeons changed very little from 2011 to 2016, found a data analysis by KHN and Johns Hopkins Bloomberg School of Public Health. Use this interactive tool to search by doctor or practicing hospital.
-
Sen. Alexander Details His Plan To Fix Surprise Medical Bills
A legislative package from Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) would handle surprise medical bills by having insurers pay them the âmedian in-network rate,â meaning the rate would be similar to what the plan charges other doctors in the area for the same procedure.
By Rachel Bluth -
Senators Agree Surprise Medical Bills Must Go. But How?
The Senate Health, Education, Labor and Pensions Committee is scheduled next week to mark up a massive legislative package on curbing health costs, but some of the details remain unresolved, including what formula to use to pay doctors and hospitals involved in surprise medical bills.
By Rachel Bluth -
Miracle Machine Makes Heroic Rescues â And Leaves Patients In Limbo
The use of ECMO, the most aggressive form of life support in modern medicine, has skyrocketed â but along with miraculous rescues, it can leave patients in limbo, kept alive with machines but with no prospect of survival outside the ICU.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
In Combating Surprise Bills, Lawmakers Miss Sky-High Air Ambulance Costs
The median cost of an air ambulance bill is more than $36,000 and seldom covered by insurance, sparking many consumer complaints. Yet none of the proposals introduced or circulating in Congress to fix surprise medical bills address these services.
By Rachel Bluth -
Trump Administration Rule Would Undo Health Care Protections For LGBTQ Patients
Supporters of the rule say it would strengthen health care professionalsâ freedom of conscience, but opponents say it âempowers bad actors to be bad actors.â
-
FDA Overlooked Red Flags In Drugmakerâs Testing of New Depression Medicine
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
FAQ: How Does New Trump Fetal Tissue Policy Impact Medical Research?
The scientific use of tissue from aborted fetuses has frequently been a hot point of contention between anti-abortion forces and researchers. It heats up again as federal officials announced this week they were ending NIH research using the tissue.
-
KHNâs âWhat The Health?â: Fetal Tissue Research Is Latest Flashpoint In Abortion Debate
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post join KHNâs Julie Rovner to discuss the Trump administrationâs efforts to curtail federally funded research using fetal tissue, the backlash from former Vice President Joe Bidenâs support for the anti-abortion Hyde Amendment and how health policy intersects with both trade and immigration policy.